Jay Backstrom
Fortune : 4 M $ au 30/06/2026
Fortune : 4 M $ au 30/06/2026
Actuellement, Jay T. Backstrom occupe le poste de vice-président exécutif et chef de la recherche et du développement chez Acceleron Pharma, Inc. Il est également membre du conseil d'administration d'Autolus Therapeutics Plc. Au cours de sa carrière, il a occupé les postes de directeur médical du Samuel U. Rodgers Community Health Center, Inc, de directeur médical en chef de Celgene Corp, de directeur exécutif des services médicaux et scientifiques de Quintiles, Inc. (Californie) et vice-président chargé des services médicaux et de la sécurité au niveau mondial chez Pharmion Corp. Il est titulaire d'un doctorat de la Temple University School of Medicine et d'un diplôme d'études supérieures de la St Louis University School of Public Health.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/03/2025 | 76 277 ( 0,07 % ) | 4 M $ | 30/06/2026 | |
| 08/07/2026 | 1 447 ( 0 % ) | 53 698 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 08/07/2025 |
Be Biopharma, Inc.
Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Directeur/Membre du Conseil | 16/12/2021 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Directeur/Membre du Conseil | 01/12/2021 |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Directeur/Membre du Conseil | 01/07/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| LAVA THERAPEUTICS | Directeur/Membre du Conseil | 07/11/2025 |
| SCHOLAR ROCK HOLDING CORPORATION | Directeur Général | 27/04/2025 |
| DISC MEDICINE, INC. | Directeur/Membre du Conseil | 09/06/2023 |
| AUTOLUS THERAPEUTICS PLC | Directeur/Membre du Conseil | 28/02/2023 |
| ACCELERON PHARMA INC. | Directeur Technique/Scientifique/R&D | 01/12/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Samuel U. Rodgers Community Health Center, Inc.
Samuel U. Rodgers Community Health Center, Inc. Samuel U. Rodgers Community Health Center, Inc. is a federally qualified nonprofit health organization dedicated to providing affordable healthcare to over 23,000 individuals annually. The private company is based in Kansas City, MO. Established in 1968, the center offers comprehensive services for all ages, including medical care, behavioral health counseling, dental and vision care, telehealth, and health insurance assistance. It provides integrated physical and mental health support, specialized programs for men’s health and maternal and infant health, and services accessible regardless of insurance status. The center is expanding its facilities to address primary care shortages and improve access for vulnerable children, and offers patient education resources, interpretation services in over 40 languages, and community partnerships to enhance care accessibility. | |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Health Services |
St Louis University School of Public Health
St Louis University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
LAVA Therapeutics NV
LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Lewis Katz School of Medicine
Lewis Katz School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Be Biopharma, Inc.
Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Health Technology |
Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national